Literature DB >> 18395086

Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner.

Michael J Hornsby1, Jennifer L Huff, Robert J Kays, Don R Canfield, Charles L Bevins, Jay V Solnick.   

Abstract

BACKGROUND & AIMS: We used the rhesus macaque model to study the effects of the cag pathogenicity island (cag PAI) on the H pylori host-pathogen interaction.
METHODS: H pylori-specific pathogen-free (SPF) monkeys were experimentally challenged with wild-type (WT) H pylori strain J166 (J166WT, n = 4) or its cag PAI isogenic knockout (J166Deltacag PAI, n = 4). Animals underwent endoscopy before and 1, 4, 8, and 13 weeks after challenge. Gastric biopsies were collected for quantitative culture, histopathology, and host gene expression analysis.
RESULTS: Quantitative cultures showed that all experimentally challenged animals were infected with J166WT or its isogenic J166Deltacag PAI. Histopathology demonstrated that inflammation and expansion of the lamina propria were attenuated in animals infected with J166Deltacag PAI compared with J166WT. Microarray analysis showed that of the 119 up-regulated genes in the J166WT-infected animals, several encode innate antimicrobial effector proteins, including elafin, siderocalin, DMBT1, DUOX2, and several novel paralogues of human-beta defensin-2. Quantitative RT-PCR confirmed that high-level induction of each of these genes depended on the presence of the cag PAI. Immunohistochemistry confirmed increased human-beta defensin-2 epithelial cell staining in animals challenged with J166WT compared with either J166Deltacag PAI-challenged or uninfected control animals.
CONCLUSIONS: We propose that one function of the cag PAI is to induce an antimicrobial host response that may serve to increase the competitive advantage of H pylori in the gastric niche and could even provide a protective benefit to the host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395086      PMCID: PMC2386437          DOI: 10.1053/j.gastro.2008.01.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

1.  Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands.

Authors:  Nicholas S Jakubovics; Nicklas Strömberg; Craig J van Dolleweerd; Charles G Kelly; Howard F Jenkinson
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

2.  Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils.

Authors:  Gabriele Rieder; Juanita L Merchant; Rainer Haas
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 3.  SLPI and elafin: one glove, many fingers.

Authors:  Steven E Williams; Thomas I Brown; Ali Roghanian; Jean-Michel Sallenave
Journal:  Clin Sci (Lond)       Date:  2006-01       Impact factor: 6.124

4.  Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene.

Authors:  Adriana Reyes-Leon; John C Atherton; Richard H Argent; J L Puente; J Torres
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

5.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron.

Authors:  Trude H Flo; Kelly D Smith; Shintaro Sato; David J Rodriguez; Margaret A Holmes; Roland K Strong; Shizuo Akira; Alan Aderem
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

6.  Molecular analysis of the bacterial microbiota in the human stomach.

Authors:  Elisabeth M Bik; Paul B Eckburg; Steven R Gill; Karen E Nelson; Elizabeth A Purdom; Fritz Francois; Guillermo Perez-Perez; Martin J Blaser; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-04       Impact factor: 11.205

7.  Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D.

Authors:  Wafa Khamri; Anthony P Moran; Mulugeta L Worku; Q Najma Karim; Marjorie M Walker; Heidi Annuk; John A Ferris; Ben J Appelmelk; Paul Eggleton; Kenneth B M Reid; Mark R Thursz
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria.

Authors:  Adam J Ratner; Jorge L Aguilar; Mikhail Shchepetov; Elena S Lysenko; Jeffrey N Weiser
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

9.  Helicobacter exploits integrin for type IV secretion and kinase activation.

Authors:  Terry Kwok; Dana Zabler; Sylwia Urman; Manfred Rohde; Roland Hartig; Silja Wessler; Rolf Misselwitz; Jürgen Berger; Norbert Sewald; Wolfgang König; Steffen Backert
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

10.  Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.

Authors:  Philip Rosenstiel; Christian Sina; Caroline End; Marcus Renner; Stefan Lyer; Andreas Till; Stephan Hellmig; Susanna Nikolaus; Ulrich R Fölsch; Burkhard Helmke; Frank Autschbach; Peter Schirmacher; Petra Kioschis; Mathias Hafner; Annemarie Poustka; Jan Mollenhauer; Stefan Schreiber
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

View more
  35 in total

1.  Life at the margins: modulation of attachment proteins in Helicobacter pylori.

Authors:  Mary E Moore; Thomas Borén; Jay V Solnick
Journal:  Gut Microbes       Date:  2011 Jan-Feb

Review 2.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

3.  Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.

Authors:  Adam Tepler; Neeraj Narula; Richard M Peek; Anish Patel; Cyrus Edelson; Jean-Frederic Colombel; Shailja C Shah
Journal:  Aliment Pharmacol Ther       Date:  2019-06-05       Impact factor: 8.171

4.  Effects of myeloid differentiation primary response gene 88 (MyD88) activation on Helicobacter infection in vivo and induction of a Th17 response.

Authors:  Marygorret Obonyo; Barry Rickman; Donald G Guiney
Journal:  Helicobacter       Date:  2011-10       Impact factor: 5.753

5.  When an Intramolecular Disulfide Bridge Governs the Interaction of DUOX2 with Its Partner DUOXA2.

Authors:  Aurore Carré; Ruy A N Louzada; Rodrigo S Fortunato; Rabii Ameziane-El-Hassani; Stanislas Morand; Vasily Ogryzko; Denise Pires de Carvalho; Helmut Grasberger; Thomas L Leto; Corinne Dupuy
Journal:  Antioxid Redox Signal       Date:  2015-04-20       Impact factor: 8.401

6.  Characterization of the Cag pathogenicity island in Helicobacter pylori from naturally infected rhesus macaques.

Authors:  Emma C Skoog; Samuel L Deck; Hasan D Entwistle; Lori M Hansen; Jay V Solnick
Journal:  FEMS Microbiol Lett       Date:  2016-12-08       Impact factor: 2.742

Review 7.  Th17 cytokines and the gut mucosal barrier.

Authors:  Christoph Blaschitz; Manuela Raffatellu
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

8.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine.

Authors:  Manuela Raffatellu; Michael D George; Yuko Akiyama; Michael J Hornsby; Sean-Paul Nuccio; Tatiane A Paixao; Brian P Butler; Hiutung Chu; Renato L Santos; Thorsten Berger; Tak W Mak; Renée M Tsolis; Charles L Bevins; Jay V Solnick; Satya Dandekar; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

Review 9.  Helicobacter pylori in health and disease.

Authors:  Timothy L Cover; Martin J Blaser
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

10.  Dual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice.

Authors:  Helmut Grasberger; Mohamad El-Zaatari; Duyen T Dang; Juanita L Merchant
Journal:  Gastroenterology       Date:  2013-07-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.